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INTRODUCTION
This proposal is concerned with enhancing the environment for healing of articular cartilage following joint injury. Recent findings suggest that chondrogenic progenitor cells (CPC) with stem cell-like characteristics may be capable of cartilage repair in the context of mechanical injury. Learning to leverage this potential for endogenous repair could provide a novel, relatively non-invasive intervention to prevent the pathogenesis of PTOA.
BODY
Experiments performed in this project yielded a number of significant and surprising results. Many of the findings that flowed from the award are detailed in the accompanying manuscript Chondrogenic Progenitors Respond to Cartilage Injury (Appendix 1), which was recently re-submitted to Arthritis and Rheumatism after a first round of largely favorable reviews. Pertinent data that were not included in the manuscript are presented in this report.
Characterization of CPCs in injured cartilage
Initially we observed migrating cells emerging on top of cartilage that had been injured by blunt impact ( Figure  1 ). As outlined in Aims 2 and 3, we focused on characterizing these injuryresponsive migrating cells. These analyses showed unequivocally that the migrating cells were chondrogenic progenitor cells (CPCs) as defined in the literature (Figure 2 ). 
(E) The graph shows real-time PCR analysis (dark columns) and microarray analysis (light columns) of marker gene expression in pCPCs relative to NCs (fold change). (F) A heatmap and dendrogram summarize microarray data for the indicated cell populations (triplicate analyses)
. Colored bars show genes that were expressed at higher or lower levels than the median value (green and red respectively). The dendrogram on the right indicates that CPCs and BMSCs were more closely related to each other than to NCs.
We found evidence to suggest that these cells originated in superficial zone of cartilage, but a firm conclusion awaits more definitive experiments that are currently underway (Section 2.5). Global analysis of gene expression revealed that the CPCs were more closely related to mesenchymal stem cells (MSCs) than to normal chondrocytes (Figure 2F, Table) . However, CPCs expressed cartilage matrix genes at higher levels than MSCs, particularly with regard to PRG4/lubricin, a critical surface lubricant made by superficial chondrocytes. This suggested that CPCs may be involved in replenishing lubricants lost as a result of injury, an activity that could help to compensate for the proteolytic loss of PRG4 and the decimation of superficial chondrocytes induced by mechanical injury. In pellet cultures under chondrogenic conditions, CPCs readily formed a cartilage-like matrix. In an explant model CPCs from the surrounding cartilage invaded fibrin-filled chondral defects and produced proteoglycans, suggesting they may be capable cartilage regeneration (Figure 3 ). Dr Seol, who was awarded a Ph.D. for his work related to this project, is pursuing optimization studies to determine if the cells can be coaxed to accelerate matrix production. These studies have focused on improving CPC infiltration in defects by brief collagenase digestion of cartilage surrounding defects and using hydrostatic or axial loading to promote chondrogenic activity. Further analysis showed that the nuclear protein highmobility group box 1 (HMGB1), one of several chemotactic "alarmins" released by dead cells, was a key factor (Figure 3) . The response to HMGB1 in CPCs was mediated by the receptor for advanced glycation end products (RAGE), an innate immune system receptor. These data suggest that HMGB1 could be used to attract increased numbers of CPCs to cartilage injuries.
Potential to exacerbate joint inflammation
The data described above seemed to support a potential reparative role for CPCs in damaged cartilage. However, additional analyses of CPC gene expression and cell behavior led us to consider a pathogenic role for CPCs. CPCs over-expressed genes encoding collagenases and other matrix proteases associated with osteoarthritis (OA). Moreover, they vastly overexpressed interleukin-6 (IL-6), and chemokines known to promote leukocyte infiltration (CXCL8, and CXCL12) (Table) . Thus there is a potential for CPCs to act as initiators and amplifiers of inflammation in injured joints. These observations filled a knowledge gap that allowed us to put forward a plausible mechanism for how intra-articular cell death contributes to post-traumatic synovitis: 1. Cells killed by joint injury release alarmins that activate CPCs locally. 2. CPCs amplify this signal through rapid proliferation and mass production of chemokines. 3. Chemokine levels in synovial fluid rise to levels that cause leukocyte infiltration resulting in synovitis.
1 
Animal models of injury
Very fortunately, a number of drugs capable of breaking the alarmin-chemokine-synovitis response are available for testing. For example, using a rabbit stifle blunt impact model we are currently running tests of n-acetyl cysteine (NAC), an agent that reduces alarmin release by reducing chondrocyte death rates. Encouraging results were seen in a recent pilot study summarized in Figure 5 . In the near future we plan to test glycyrrhizin, a natural product that chelates HMGB1, effectively blocking CPC activation. These studies will help to determine if on balance CPCs activities are beneficial or harmful. 
Patient studies
In addition to work the in vivo model described above, we are pursuing patient studies aimed at estimating the alarmin/chemokine burden in synovial fluids and effusions drawn at the time of injury and weeks later at the time of surgery ( Figure 6 ). As the alarmin hypothesis applies to any insult that results in extensive intra-articular cell death, we plan to follow a broad range of injuries including intra-articular fractures of the ankle and ligamentous injuries in the knee. A joint fluid repository has been established in the Orthopaedic Biology Laboratory to facilitate these studies. The study is expected to reveal if alarmin/chemokine levels will correlate with imaging-based estimates of injury severity.
Novel means to identify resident CPCs
Our thorough molecular characterization of injury-responsive CPCs has enabled us to develop new markers that may be useful for identifying CPCs in cartilage specimens before they migrate to the surface. Previous attempts to distinguish CPCs residing in the matrix from normal chondrocytes based on expression of stem-cell or other markers have not been successful. On the other hand, our findings showed that upon exposure to alarmins, CPCs express a number of genes at levels that were 10-fold or more higher than normal chondrocytes. Based on this we hypothesized that an alarmin "challenge" would stimulate gene over-expression by CPCs resident in the matrix. We are currently testing this idea using immunostaining to localize such gene products (CXCL8 and 12 as well as IL-6) in cartilage at various times after alarmin exposure ( Figure 7 ). If our hypothesis is correct, this technique will definitively determine the origins of CPCs. Moreover, we expect that the challenge approach could be used to assay for CPCs in cartilage samples from people of various ages to determine if their numbers decline with age. 2.6 Departures from the S.O.W. In using an explant impact injury model rather than the ex-vivo fracture model our studies departed significantly from the plan described in the SOW. The decision to stay with the explant model was strategic and based on advances that occurred after the SOW was written. First, it became clear that Dr. Tochigi would produce animal models, including rabbit impact and a porcine intra-articular fracture model, sooner than we had expected. The opportunity to skip directly to in vivo systems made the ex vivo fracture model somewhat less attractive as a stepping stone. At the same time we were learning from the explant model about the mechanics of CPC homing and their potential for harm. The findings were so novel and significant that we felt compelled to pursue them to a publishable conclusion.
KEY RESEARCH ACCOMPLISHMENTS:
• Repository: A repository of joint fluids from patients with intra-articular fracture and ACL injuries has been established in the Orthopaedic Biology Laboratory. The samples will be assayed for alarmins, chemokines and cytokines present in joint fluids in the first few weeks after injury Funding: We are planning to submit proposals based on this project to the Veterans Administration and Arthritis Foundation. Funding will be used to pursue work in animal models.
CONCLUSION:
Our results to date have broken new ground with respect to understanding how CPCs function in articular cartilage injuries. While the data show there is a potential for CPC-based cartilage repair, our new findings that implicate CPCs in acute post-traumatic inflammation challenge conventional wisdom that progenitor cells should benefit healing. In addition, our gene expression data have equipped us with new methods for distinguishing CPCs from normal chondrocytes, which will be particularly useful for studying aging effects on CPC populations and for identifying CPCs in the complex milieu of the living joint. The discovery of the role of HMGB1 as a major CPC activator and chemotactic factor provides a means to manipulate the cells to either block or enhance their activation. Hence we are now in an excellent position to test hypotheses regarding the effects of CPC in in vivo models of joint injury where interactions with the immune system will be of particular interest.
Introduction
The risk for post-traumatic osteoarthritis (PTOA) after serious joint injuries still runs as high as 70% despite many refinements in care (1) (2) (3) CPCs were first identified in calf cartilage as a sub-population of superficial zone cells required for the appositional growth of articular cartilage (5, 14) . The specialized population was isolated from other cartilage Necrotic cell death associated with wounding releases intracellular components that serve as chemotactic signals for progenitor and stem cells, and leukocytes. Known collectively as "alarmins" or dangerassociated molecular patterns (DAMPs) they include mitochondrial DNA and formyl methionine (fMet)
containing peptides and DNA-binding high mobility group proteins such as HMGB1 and 2, and multiple S100
proteins (18) (19) (20) (21) . Alarmin binding to RAGE and toll-like receptors (TLRs) stimulates the migration of progenitor and stem cells, attracting them to injury sites where they participate in tissue regeneration and repair (22) (23) (24) (25) . The potent anti-inflammatory drug glycyrrhizic acid is a natural product derived from licorice that binds HMGB1 and blocks its activities (26) . Additional chemotactic recruitment is stimulated by C-X-C motif ligands (CXCL) released by tissue and inflammatory cells (27, 28) . A number of studies have shown that blunt trauma to articular cartilage induces acute chondrocyte necrosis and apoptosis (1, (29) (30) (31) (32) (33) (34) (35) . In an explant trauma model we found cells migrating over cartilage surfaces near sites of extensive chondrocyte death. These cells were isolated and evaluated for progenitor characteristics and chemotactic responses to injury-related alarmins.
Materials and Methods
Bovine stifle joints from young adult cattle (15-24 months-old) were obtained from a local abattoir fetal bovine serum (Invitrogen TM Life Technologies, Carlsbad, CA), 50 μg/ml L-ascorbate, 100 U/ml penicillin, 100 μg/ml streptomycin, and 2.5 μg/ml Fungizone.
After two days in culture the human and bovine explants were injured by blunt impact (14 J/cm 2 ) via a 5
mm-diameter flat-ended platen using a drop tower device as described previously (35, 36) . In some cases explant cartilage was dissected free from subchondral bone immediately after impact injury. Scratch injuries were made by dragging a 26 gauge needle over the cartilage surface to create X-shaped matrix tears ~ 0.5 mm in depth. Confocal imaging studies were performed essentially as described (35, 36) . Briefly, explants were stained with calcein AM (viability) and ethidium homodimer (dead cells) and submerged in culture medium.
After a 30-minute incubation the explants were imaged using a Bio-Rad 1024 laser scanning confocal microscope (LSCM) (Bio-Rad Laboratories Inc., Hercules, CA).
Five to seven days post-injury explants were submerged in 0.25% trypsin-EDTA in HBSS and were incubated for 10 minutes to detach migrating progenitor cells from the surface. Pre-and post-trypsin imaging studies confirmed that the brief enzymatic treatment removed the surface-adherent migrating cells without disrupting the underlying superficial chondrocytes. To recover normal chondrocytes the underlying cartilage was digested overnight with collagenase type 1 and pronase E (Sigma-Aldrich, St. Louis, MO) dissolved in culture medium (0.25 mg/ml each). A custom-fabricated device was used to separate the superficial 1/3 and lower 2/3 of the cartilage samples zones prior to collagenase/pronase digestion. Colony forming assays were performed as previously described (37) .
For some experiments isolated pCPCs cells were labeled with Green Fluorescent Protein (GFP, 488 nm) by lentiviral transduction. GFP-labeled cells (1x10 5 ) were suspended in a chilled (8°C) hydrogel consisting of 0.6% 2KDa hyaluronic acid (Easy Motion Horse, Niagara Falls, NY) and 18% Pluronic F-127 (Sigma-Aldrich) in normal saline. Pluronic F-127 is a polyol surfactant that confers temperature-sensitive gelation to solutions (38) . The cold suspension gelled on contact with warmed (37 o C) explants, such that the suspended cells were held in place adjacent to a blunt impact site. The explants were incubated for 5 days when they were counterstained with 0.5 µM Cell Tracker Red CMTPX (Invitrogen TM Life Technologies) and imaged on a BioRad 1024 confocal microscope with the custom-built x-y microscope stage driver (CMSD). The sites were scanned to an average depth of 330 µm at 40 µm intervals. Z-axis projections of confocal images were made using ImageJ (rsb.info.nih.gov/ij).
Immunofluorescence staining for proliferating cell nuclear antigen (PCNA) was performed on paraformaldehyde-fixed cryosections of cartilage from three different explants that had been cultured for 10 days after an impact injury using a monoclonal anti-PCNA antibody (Abcam, Cambridge, MA) and a goat anti- Cell migration/chemotaxis assays were performed using CytoSelect™ 24-Well Cell Invasion Assay kit (Cell Biolabs Inc., San Diego, CA) essentially as described by the manufacturer. pCPC or NC suspensions (3x10 5 cells in serum-free medium) were added to the upper transwell and placed in reservoirs containing serum-free medium alone or serum-free medium with various chemokines, cell lysates, or serum-free medium conditioned by injured explants. The plates were incubated for 24 hours, prior to processing. Cell lysates were transferred to fluorescence plates and read on a microplate reader (Molecular Devices Inc., Sunnyvale, CA).
The data are presented as the percentage of migrating cells (# in the bottom chamber / # seeded x 100).
Conditioned medium was made by incubating blunt-impacted explants overnight in 10 ml serum-free medium.
The medium was concentrated 10-fold using Amicon ® Ultra centrifugal Filters 10K (Millipore, Billerica, MA).
Lysates for testing in the chemotaxis assay were obtained by repeated freeze-thawing of cells from primary cultures of bovine chondrocytes isolated from distal femurs. Glycyrrhizic acid (Sigma-Aldrich) and a rabbit polyclonal anti-RAGE antibody (Abcam) were added to culture media at a concentration of 25 μM (39).
Porcine platelet-derived growth factor (PDGF-BB) (R&D Systems, Minneapolis, MN) was diluted in medium to a concentration of 300 nM (40) . The effects of glycyrrhizic acid and anti-RAGE antibody on migration in the explant model were assessed by confocal microscopy and by counting migrating cells harvested from explant surfaces by trypsinization at 14 days post-impact. The explants (n = 4/group) were treated daily starting immediately after impact.
Side population assays were performed essentially as described (7) . First passage pCPCs and NCs in suspension in HBSS (1x10 6 /ml) were incubated at 37°C for 1.5 hours with Hoechst-33342 (Sigma-Aldrich) at 
Results
Blunt impact-injury to explant surfaces caused local chondrocyte death and stimulated the emergence of migratory cells in and around impact sites. These cells began to accumulate 5 days after impact and gradually repopulated previously uninhabited areas ( Figure 1A-C) . Migrating cells were morphologically distinct from NCs in that they were elongated with multiple thin cytoplasmic extensions ( Figure 1D) . A similar migratory reaction was observed at impact sites in explanted human tali, one of which is shown ( Figure 1E and F) and in a scratch injury ( Figure 1G and H). Migrating cells were also observed on impacted explant cartilage cultured without subchondral bone. A specimen representative of three such explants is shown ( Figure 1I ).
Immunostaining of cryosections from impacted explants revealed that surface-migrating pCPCs were positive for PCNA, whereas chondrocytes beneath the surface were largely negative ( Figure 1J ). Surface pCPCs were also strongly positive for lubricin ( Figure 1K ). or lower 2/3 of the matrix, which both showed averages of less than 5 mm 2 (p = 0.001). However, ~1% of the colonies formed by upper 1/3 chondrocytes showed areas of 20 mm 2 or greater.
pCPCs were cultured in chondrogenic, osteogenic, or adipogenic media for 14 days to evaluate their differentiation potential. After the induction of chondrogenic differentiation, cultured pellets were fixed and stained with Safranin-O/fast green, revealing a proteoglycan-rich matrix throughout the pellets ( Figure 4A ).
Similarly, most cells in osteogenic medium deposited a calcium phosphate-rich mineralized matrix as detected by Alizarin Red staining ( Figure 4B ). However, few cells (< 1%) stained with Oil Red O after 2 weeks of culture in adipogenic medium ( Figure 4C ).
Flow cytometric analysis of Hoechst-stained NCs revealed few side population cells (0.032 +/-0.012%) ( Figure 4D ). The side population was significantly larger in trypsinized cells (0.22 +/-0.07%, p=0.001).
Verapamil treatment reduced side populations to less than 0.005%, indicating that stain efflux depended on the stem cell-associated ABCG2 transporter. Real-time PCR analysis revealed substantially higher expression of stem cell marker genes in pCPCs versus NCs ( Figure 4E ). ABCG2 was increased by over 4-fold, Sox-9 by 3.8-fold, and FLK-1 by 2.8-fold. CD105, CD73, CD39, and CD29 were increased by less than 2-fold in pCPCs and CD90 was 2-fold higher in NCs than in pCPCs. Microarray analysis showed elevated expression of the progenitor cell markers Notch1 (7.4-fold) and CD44 (12-fold) in pCPCs compared to NCs.
Statistical analysis of microarrays indicated that overall gene expression in pCPCs was more similar to that of MSCs than NCs ( Figure 4F ). Individual genes that showed statistically significant differences in expression (p<0.05) of greater than 2-fold in pCPCs versus NCs or MSCs are listed (Table) . The listed genes were selected for relevance to inflammation, proliferation, migration, and chondrogenic differentiation. The pro-inflammatory cytokine IL-6 was among the most highly up-regulated genes in CPCs compared with NCs (130-fold increase). Chemokines involved in stem cell and leukocyte chemotaxis (28, 43) were also strikingly up-regulated in pCPCs relative to NCs: CXCL12 expression was more than 25 times greater and CXCL8 (IL8)
increased by more than 35-fold. Also relative to NCs, the matrix metalloproteinases, MMP1 and MMP13, were over-expressed in pCPCs by 18-and 4.3-fold respectively and the proliferation-related cyclins B1 (CCNB1) and D1 (CCND1) were over-expressed by 35-and 9-fold respectively. Relative to NCs, genes encoding the cartilage extracellular matrix components collagen type X (COL10A1), type IX (COL9A2), and type II (COL2A1), aggrecan (ACAN), and cartilage oligomeric matrix protein (COMP) were among the most downregulated genes in pCPCs. However, versus MSCs, pCPCs over-expressed the superficial chondrocyte marker PRG4 (proteoglycan-4/lubricin), and the chondrocyte-associated genes S100A1 (16-fold) and S100B (2.6-fold). Moreover, ACAN and COL2A1 expression was much higher in pCPCs than in MSCs (17 and 6.9-fold increases respectively). In contrast, the gene for the interleukin 1 receptor antagonist (IL1RN) was substantially down-regulated in pCPCs versus MSCs (-3.6-fold), as were several insulin-like growth factor binding proteins including IGFBP7 (-10-fold), IGFBP3 (-5.4-fold), and IGFBP2 (-3.6-fold).
In general, pCPCs were significantly more active in transwell chemotaxis assays than NCs (p=0.001),
however this was factor-dependent ( Figure 5A ). Compared with untreated control medium, CXCL12
significantly increased pCPC chemotaxis (p=0.001), but had no effect on NCs (p=0.411). Neither pCPCs nor
NCs responded to CXCL8 (p=0.128 and 0.912 respectively), but conditioned medium from impact-injured explants induced chemotaxis to a similar degree in both pCPCs and NCs (p=0.001). The response to cell lysates was significant for pCPCs and NCs (p=0.001), but the pCPC response was significantly greater than the NC response (p=0.001). In addition to cell lysates and conditioned medium, pCPCs responded strongly to purified HMGB1 ( Figure 5B ). HMGB1 at 10 or 20 nM significantly enhanced chemotaxis compared with controls (p=0.001). The stimulatory effects of 10 nM HMGB1 and the effects of conditioned media and cell lysates were significantly suppressed by glycyrrhizin and by an antibody to the AGE receptor (p=0.001). The migratory activity stimulated by lysates, conditioned medium and 10 nM HMGB1 were similar to the activity stimulated by PDGF (250 nM), a well-known stem cell chemotactic factor. Glycyrrhizin and the anti-RAGE antibody also significantly inhibited pCPC migration in impacted explants (p = 0.016 and 0.011 respectively) ( Figure 5C ).
Discussion
The results of these experiments demonstrate that the migrating cells we observed on injured bovine osteochondral explants closely resembled chondrogenic progenitors previously identified in normal and osteoarthritic human cartilage. The cells' chemotactic activity, clonogenicity, limited multipotency, and side population were all notably consistent with published descriptions of progenitor cells from cartilage and other tissues (6, 8, 14, 15, 17) .
In vitro chemotaxis assays confirmed that medium conditioned by impacted cartilage or cell lysates were relatively strong chemoattractants for pCPCs. Furthermore, a scratch injury that caused localized chondrocyte death much like that observed in impact sites provoked the same response as impact injury, indicating that chondrocyte death was the main cause of pCPC activation in this system. The strong blocking effects of glycyrrhizin in the migration assays implicated the nuclear protein HMGB1 as a primary chemoattractant in these complex mixtures. A blocking antibody to the RAGE receptor also significantly diminished migration, indicating that HMGB1 effects were mediated in part by RAGE. The inhibitory effects of glycyrrhizin and anti-RAGE on pCPC migration/proliferation in the explant system were also significant; however, the treatments were less potent than in transwell migration assays, suggesting that other factors contributed to the chemotactic activity. Indeed, our data suggest that PDGF might play such a role. A similar migratory response was observed in explanted human tali with the same impact injuries as bovine explants, indicating that pCPC activation was not unique to the bovine system. pCPCs appeared after injury when cartilage was cultured separately from subchondral bone. Cell populations derived from the top 1/3 of the cartilage matrix consistently yielded a few colonies that were as large as those formed by pCPCs, whereas cells from the bottom 2/3 of the matrix never formed such colonies.
Moreover, PRG4, which is expressed at high levels by superficial chondrocytes, was one of the most highly upregulated genes in pCPCs relative to MSCs. These findings strongly suggest that pCPCs resided in the superficial zone before cartilage injury.
Compared with NCs, pCPCs over-expressed a few, but not all stem cell-associated markers; while ABCG2, Runx2, and Notch1 expression were up by 4-fold or more in pCPCs, increases in CD markers were minor (< 2-fold) and not likely to be biologically significant. These results mainly agree with previous work (5, 7, 15, 17) , but the lack of substantive increases in CD marker expression suggests the pCPCs studied here might differ from progenitors of sub-chondral origin that more clearly over-express these markers (17) . Relative to NCs, CPCs under-expressed chondrocyte-associated genes such as COL2A1 and ACAN. However, compared with MSCs, pCPCs over-expressed COL2A1, ACAN, PRG4, S100A1, and S100B, all of which are considered to be chondrocyte markers (44) . Thus, although they more closely resembled MSCs in their overall pattern of gene expression, pCPCs retained some chondrocyte-like features and were distinguishable from MSCs on that basis.
The expression of several matrix proteases (MMP1, MMP13, ADAMTS4, ADAM8, and ADAM9) was significantly higher in pCPCs than in NCs. This was consistent with the enhanced chemotactic activity of pCPCs compared with NCs in our transwell-based assays, which measured movement through a collagen matrix. With the notable exceptions of MMP1 and MMP13, which were upregulated by more than 4-fold in pCPCs, matrix proteases were expressed at similar levels by MSCs, whose physiologic functions include migration through extracellular matrices.
The accumulation of hundreds of pCPCs at injury sites was unlikely to be due solely to migration from the surrounding matrix. pCPCs grew rapidly in culture and proliferation on cartilage surfaces is likely to explain the rapid repopulation of impact sites in the explant model. This was corroborated by immunofluorescence staining, which identified relatively high numbers of PCNA-positives among surface migrating cells. Consistent with their highly clonogenic, proliferative phenotype, both MSCs and pCPCs significantly over-expressed CSF (colony stimulating factor), cyclins, and other growth-related genes.
The circumstances of the explant experiment dictated that we use different techniques to harvest RNA from CPCs and NCs: CPC RNA was from cells freshly removed from explant surfaces by trypsinization and NC RNA was extracted directly from cartilage and MSC RNA was from primary monolayer cultures. Although the trypsin treatment of CPCs was brief (~10 minutes), it might have led to changes in the expression of some early response genes. Moreover, procedural losses associated with RNA extraction from cartilage might have contributed to variability among the NC samples, which was higher than in pCPC or MSC samples. Lastly, the effects of isolation and short-term culture on MSC gene expression are unknown and might have affected many of the genes that appeared to be differentially regulated versus pCPC and NC.
The physiologic functions of CPCs and their effects on healing in injured joints remain unknown.
Although CPCs efficiently re-populated damaged cartilage in our model, their relatively high levels of chemokine and cytokine expression and excessive matrix protease production could contribute to synovitis and cartilage degeneration in injured joints. On the other hand, CPCs may be involved in the early stages of cartilage repair: confocal studies and histology showed that pCPCs formed a continuous sheet over injured cartilage surfaces after a week or more in culture. The relatively high level of PRG4 expression by CPCs observed at the RNA and protein levels suggests they help to restore the surface-protective lubricant coating on damaged cartilage, a process that may be involved in the repair of superficial defects (1, (45) (46) (47) (48) (49) . The identification of HMGB1 as an activator suggests a method to control CPC responses to promote healing.
Whether the goal should be to thwart or augment these responses will likely be decided by findings from in vivo models, where treatments can be evaluated in a more physiologic setting. 
